Scientists have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building blocks that influence how drugs interact with the body.

Johnson & Johnson (NYSE: JNJ) has kicked off construction on a $2 billion biologics manufacturing facility in Eastern North ...

Johnson & Johnson will invest $55 billion in the U.S. over the next four years. The announcement comes a month after Eli ...

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...

MUMBAI, India and Oldenzaal, Netherlands, March 21, 2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma ...

In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The marketing authorization is granted to Telix’s partner R2PHARMA, Brazil’s leading cold kit manufacturer, nuclear pharmacy and cyclotron network, and a subsidiary of GSH Corp Participações S.A.

MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...

Shonubi Musoke & Co. Advocates, one of Uganda's premier law firms and a partner of the globally renowned Norton Rose Fulbright, advised XRP Healthcare in this transaction, ensuring a seamless legal ...

Collegium Pharmaceutical Inc. is a ... That means no competition until 2027/28. The company has secured a generic agreement with Hikma for production of the drug post-exclusivity period.